Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Accenture
Federal Trade Commission
Cerilliant
Chubb
Fish and Richardson
Julphar
McKesson
Baxter
AstraZeneca

Generated: April 22, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 072538

« Back to Dashboard

NDA 072538 describes BETAMETHASONE DIPROPIONATE, which is a drug marketed by Fougera Pharms, Glenmark Generics, Perrigo New York, Taro, Tolmar, Actavis Mid Atlantic, Pharmaderm, Teva, Teligent Pharma Inc, Alpharma Us Pharms, Fougera Pharms Inc, G And W Labs Inc, and Hi-tech Pharmacal, and is included in thirty-eight NDAs. It is available from fourteen suppliers. Additional details are available on the BETAMETHASONE DIPROPIONATE profile page.

The generic ingredient in BETAMETHASONE DIPROPIONATE is betamethasone dipropionate. There are sixty-six drug master file entries for this compound. Seventeen suppliers are listed for this compound. Additional details are available on the betamethasone dipropionate profile page.
Summary for 072538
Tradename:BETAMETHASONE DIPROPIONATE
Applicant:Perrigo New York
Ingredient:betamethasone dipropionate
Patents:0
Therapeutic Class:Hormonal Agents, Stimulant/Replacement/Modifying (Adrenal)
Formulation / Manufacturing:see details
Pharmacology for NDA: 072538
Suppliers and Packaging for NDA: 072538
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
BETAMETHASONE DIPROPIONATE betamethasone dipropionate LOTION;TOPICAL 072538 ANDA Perrigo New York Inc 45802-021 N 45802-021-46

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:LOTION;TOPICALStrengthEQ 0.05% BASE
Approval Date:Jan 31, 1990TE:ABRLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Farmers Insurance
Colorcon
UBS
Mallinckrodt
Julphar
Boehringer Ingelheim
Teva
US Department of Justice
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.